How to translate text using browser tools
2 January 2023 Impacts of Bioassay Type on Insecticide Resistance Assessment in the German Cockroach (Blattodea: Ectobiidae)
Madison P. Gits, Ameya D. Gondhalekar, Michael E. Scharf
Author Affiliations +

The German cockroach, Blattella germanica (L.), is one of the most critical urban pests globally due to the health risks it imposes on people, such as asthma. Insecticides are known to manage large cockroach population sizes, but the rapid rate at which they develop resistance is a continuing problem. Dealing with insecticide resistance can be expensive and time-consuming for both the consumer and the pest management professional (PMP) applying the treatment. Each cockroach population is unique because different strains have different insecticide susceptibilities, so resistance profiles must be considered. This study addressed the above issue in a controlled laboratory setting. Cockroach strains from Indianapolis, Indiana, Danville, Illinois, and Baltimore, Maryland, USA were used. Four insecticide active ingredients (AIs) most used by consumers and PMPs were selected for testing in vial bioassays to establish resistance profiles. Next, no-choice and choice feeding assays with four currently registered bait products were performed to assess the impacts of competing food and circadian rhythms on bait resistance levels. The results indicate that emamectin benzoate (Optigard) was the most effective AI in causing the highest mortality in all strains in vial and no-choice bioassays; whereas, the other AIs and products were more impacted by resistance. The results acquired from these studies can help develop rapid tests for use by PMPs based on the no-choice feeding assay while also adding more information supporting current resistance and cross-resistance evolution theories.

Madison P. Gits, Ameya D. Gondhalekar, and Michael E. Scharf "Impacts of Bioassay Type on Insecticide Resistance Assessment in the German Cockroach (Blattodea: Ectobiidae)," Journal of Medical Entomology 60(2), 356-363, (2 January 2023).
Received: 14 September 2022; Accepted: 19 December 2022; Published: 2 January 2023

This article is only available to subscribers.
It is not available for individual sale.

Emamectin benzoate
Get copyright permission
Back to Top